|
Leukemia, Chronic Myelogenous
|
|
|
Leukemia, Chronic Myelogenous Clinical Trials
- Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002592 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
- BAY 43-9006 in Treating Patients With Imatinib Mesylate-Resistant Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00085007 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002674 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00005948 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
- Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00011934 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00002789 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00112801 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002778 - Active, not recruiting
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
- Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003239 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
- BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00064233 - Active, not recruiting
chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00004052 - Active, not recruiting
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
- Oblimersen Plus Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00049192 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003727 - Active, not recruiting
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- BMS-354825 in Treating Patients With Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia That Did Not Respond to Previous Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00110097 - Active, not recruiting
blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
- Fludarabine and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00119340 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
- BMS-354825 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00108693 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- BMS-354825 in Treating Patients With Blastic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00108719 - Active, not recruiting
blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon alfa
ClinicalTrials.gov Identifier: NCT00004933 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002761 - Active, not recruiting
relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
- STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis
ClinicalTrials.gov Identifier: NCT00006475 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; Philadelphia chromosome negative chronic myelogenous leukemia; ...
- Interferon alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002869 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00030303 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Interferon alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00045422 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00112775 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase
ClinicalTrials.gov Identifier: NCT00003694 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
- Cyclophosphamide and Filgrastim Followed By Peripheral Stem Cell Transplantation in Treating Patients With Chronic or Accelerated Phase Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00005984 - Recruiting
chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
- Interferon alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003561 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
chronic phase chronic myelogenous leukemia
- Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00012259 - Active, not recruiting
relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia
- Chemotherapy, Biological Therapy, and/or Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00025402 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00028847 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- CCI-779 and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00101088 - Recruiting
accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
- Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00023881 - Completed
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
- Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00053248 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004878 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Graft Versus Host Disease; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- Chemotherapy, Low-Dose Total-Body Irradiation, and Peripheral Stem Cell Transplantation Followed By Chemotherapy and Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00003145 - Active, not recruiting
chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
- STI571 in Treating Patients With Recurrent Leukemia
ClinicalTrials.gov Identifier: NCT00004932 - Active, not recruiting
recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; relapsing chronic myelogenous leukemia; ...
- STI571 Compared With Interferon alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006343 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Quality of Life
- Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002833 - Active, not recruiting
Chronic Myelogenous Leukemia; Graft vs Host Disease; Philadelphia chromosome; Myeloid Leukemia; Refractory Anemia; Chronic Myelomonocytic Leukemia
- Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002771 - Active, not recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00070499 - Recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00054431 - Completed
accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
- Gleevec Trial in Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00081926 - Active, not recruiting
Chronic Myelogenous Leukemia
- STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006052 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
ClinicalTrials.gov Identifier: NCT00098436 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
- Efficacy, Safety and Long-Term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)
ClinicalTrials.gov Identifier: NCT00237120 - Active, not recruiting
Chronic Myelogenous Leukemia in Chronic Phase
- AG-858 and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Were Previously Treated With Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00070395 - Recruiting
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00333840 - Active, not recruiting
Chronic Myelogenous Leukemia
- Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00002800 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; untreated adult acute myeloid leukemia; de novo myelodysplastic syndrome; ...
- Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors
ClinicalTrials.gov Identifier: NCT00580281 - Recruiting
Gastric Cancer; Leukemia; Chronic Myelogenous Leukemia
- Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002890 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Previously Treated Myelodysplastic Syndrome; recurrent adult acute myeloid leukemia; ...
- Stem Cell Transplantation for Patients With Cancers of the Blood
ClinicalTrials.gov Identifier: NCT00467961 - Recruiting
CML (Chronic Myelogenous Leukemia); CLL (Chronic Lymphocytic Leukemia); AML (Acute Myelogenous Leukemia); ALL (Acute B-Lymphoblastic Leukemia); MDS (Myelodysplastic Syndrome)
- Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) with Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
ClinicalTrials.gov Identifier: NCT00038649 - Active, not recruiting
Myelogenous Leukemia, Chronic, Chronic Phase
- Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
ClinicalTrials.gov Identifier: NCT00378534 - Recruiting
Chronic Myelogenous Leukemia; Acute Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome
- STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon alfa
ClinicalTrials.gov Identifier: NCT00006053 - Completed
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
ClinicalTrials.gov Identifier: NCT00015951 - Active, not recruiting
recurrent adult acute myeloid leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
- A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
ClinicalTrials.gov Identifier: NCT00471497 - Recruiting
Myelogenous Leukemia, Chronic
- Investigation of Clofarabine in Acute Leukemias
ClinicalTrials.gov Identifier: NCT00098033 - Active, not recruiting
Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia
- Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006364 - Completed
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
- STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00015834 - Completed
relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00066326 - Completed
blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- Study Evaluating the Safety and Efficacy of AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
ClinicalTrials.gov Identifier: NCT00241358 - Recruiting
Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome; Chronic Myelogenous Leukemia; Non-Hodgkin Lymphoma; Hodgkin's Disease; Chronic Lymphocytic Leukemia; Multiple Myeloma
- Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment
ClinicalTrials.gov Identifier: NCT00072579 - Completed
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
ClinicalTrials.gov Identifier: NCT00002766 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; adult acute lymphoblastic leukemia; adult lymphoblastic lymphoma; ...
- Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment
ClinicalTrials.gov Identifier: NCT00006091 - Completed
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
- Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00030394 - Completed
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00110058 - Completed
accelerated phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00100997 - Completed
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
- Study Comparing Standard Dose and High-Dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov Identifier: NCT00171899 - Recruiting
Chronic Myelogenous Leukemia
- An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00346632 - Recruiting
Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Chronic Myelogenous Leukemia
- Clofarabine and AraC for the Treatment of AML, MDS
ClinicalTrials.gov Identifier: NCT00334074 - Active, not recruiting
Acute Myelogenous Leukemia; Myelodysplastic Syndromes; Chronic Myelogenous Leukemia
- Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00270881 - Recruiting
Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00005618 - Completed
accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia; ...
- Study of BMS-354825 in Patients with Accelerated Phase Chronic Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00101647 - Active, not recruiting
Chronic Myelogenous Leukemia
- Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00015847 - Completed
relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
ClinicalTrials.gov Identifier: NCT00412360 - Recruiting
Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome
- PH III Chronic CML - Follow On
ClinicalTrials.gov Identifier: NCT00123474 - Active, not recruiting
Chronic Phase Chronic Myelogenous Leukemia
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
Leukemia, Myeloid; Leukemia, Myeloid, Chronic
- Combination Chemotherapy and Interferon alfa in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002598 - Completed
relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; atypical chronic myeloid leukemia
- A Study of Oral AMN107 in Adult Patients with Chronic Myelogenous Leukemia or other Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00109707 - Recruiting
Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Philadelphia Chromosome; Hypereosinophilic Syndrome; Systemic Mastocytosis
- Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Allogeneic Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00055874 - Recruiting
chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00015860 - Completed
recurrent adult acute lymphoblastic leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia
- Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006092 - Completed
recurrent adult acute lymphoblastic leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
- Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma
ClinicalTrials.gov Identifier: NCT00002681 - Active, not recruiting
recurrent adult Hodgkin's lymphoma; recurrent adult acute myeloid leukemia; relapsing chronic myelogenous leukemia; ...
- Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00093639 - Completed
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003735 - Active, not recruiting
recurrent childhood acute myeloid leukemia; recurrent childhood acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia
- Allogeneic Transplantation for Patients With Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00185523 - Recruiting
Leukemia, Lymphocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic
- Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00002809 - Active, not recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ...
- A Study of Imatinib Versus Nilotinib in Adult Patients With a Suboptimal Cytogenetic Response With Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
ClinicalTrials.gov Identifier: NCT00519090 - Not yet recruiting
Myelogenous Leukemia
- Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
ClinicalTrials.gov Identifier: NCT00036738 - Recruiting
recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia; ...
- Study of Dasatinib in Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00254423 - Recruiting
Chronic Myelogenous Leukemia
- Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00022490 - Completed
chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
- Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant
ClinicalTrials.gov Identifier: NCT00002790 - Active, not recruiting
Chronic Myelogenous Leukemia; Graft Versus Host Disease; childhood acute lymphocytic leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia; ...
- Phase II/III Randomized Study of Transplantation With Unmodified Versus T-Cell Depleted, Unrelated Allogeneic Bone Marrow in Patients With Leukemia
ClinicalTrials.gov Identifier: NCT00006451 - Active, not recruiting
acute undifferentiated leukemia; accelerated phase chronic myelogenous leukemia; Graft Versus Host Disease; ...
- Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin''s Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00275080 - Recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Adult Non-Hodgkin''s Lymphoma; Adult Solid Tumor; Chronic Myelogenous Leukemia
- Phase II Study of Intensive Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantion in Patients With Chronic Myelogenous Leukemia or High Risk Acute Leukemia
ClinicalTrials.gov Identifier: NCT00004905 - Completed
adult acute myeloid leukemia in remission; chronic phase chronic myelogenous leukemia; recurrent adult acute myeloid leukemia; ...
- Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00301093 - Active, not recruiting
Leukemia
- Imatinib Mesylate in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00324636 - Active, not recruiting
Leukemia
- 17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00098423 - Recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; ...
- Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant
ClinicalTrials.gov Identifier: NCT00571662 - Recruiting
Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplastic Syndromes; Multiple Myeloma; Non-Hodgkins Lymphoma; Hodgkins Disease; Peripheral T-Cell Lymphoma
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
